DISTINCT evolutionary pathways of OMICRON subvariants "Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2" https://t.co/gKXSLYihck https://t.co/yNMdyO4KAe
Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Mar 2023 – Feb 2024Where it's discussed
-
X / Twitter11 posts
-
News2 articles
-
YouTube1 videos
AI synopsis
What people are saying
The discussions reveal a strong focus on the variant's evolution and implications, with phrases like 'distinct pathways' and 'immune evasion' indicating deep interest and engagement. The tone is scientifically curious and cautious, reflecting both excitement over new insights and concern over ongoing challenges in managing these variants.
Most discussions acknowledge the importance of the research, highlighting the evolving nature of SARS-CoV-2 variants and their implications for immunity.
Participants appear highly interested, frequently referencing the specific variant (BA.2.75) and emphasizing the significance of antibody evasion and affinity changes.
Comments often include references to the evolutionary pathways and potential public health consequences, indicating active engagement.
The discussions suggest the research could impact ongoing vaccine development and public health strategies, though some focus remains on understanding rather than immediate action.
Abstract in brief
- The Omicron BA275 sublineage of SARS-CoV-2 has evolved into multiple variants with different spike mutations, notably CH11 and BN1, which are increasing in prevalence worldwide.
- Two main evolutionary pathways have emerged: one producing variants like CH11 with decreased receptor affinity but high antibody resistance, and another like BN1 with increased receptor affinity and moderate antibody evasion.
- Most circulating variants, except BN1, show strong antibody escape, highlighting that immune evasion is the key factor driving the current transmissibility of SARS-CoV-2.]
Top posts
Most liked on X and BlueskyEvolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2 https://t.co/RJ1bd3KNEO #biorxiv_micrbio
Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2 https://t.co/eIDiE7vPie #bioRxiv
RT @ejustin46: DISTINCT evolutionary pathways of OMICRON subvariants "Evolving antibody evasion and receptor affinity of the Omicron BA.2.…
Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2 https://t.co/z6o9YWg8J0
RT @ejustin46: DISTINCT evolutionary pathways of OMICRON subvariants "Evolving antibody evasion and receptor affinity of the Omicron BA.2.…
All mentions
Evolution of SARS-CoV-2 Omicron BA.2.75 and Its Impact on Viral Spread
The Omicron BA.2.75 sublineage of SARS-CoV-2 has evolved into multiple variants with different spike mutations, notably CH11 and BN1, which are increasing in prevalence worldwide. Variants show varying receptor affinity…
Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2 https://t.co/z6o9YWg8J0
RT @ejustin46: DISTINCT evolutionary pathways of OMICRON subvariants "Evolving antibody evasion and receptor affinity of the Omicron BA.2.…
RT @ejustin46: DISTINCT evolutionary pathways of OMICRON subvariants "Evolving antibody evasion and receptor affinity of the Omicron BA.2.…
RT @ejustin46: DISTINCT evolutionary pathways of OMICRON subvariants "Evolving antibody evasion and receptor affinity of the Omicron BA.2.…
RT @ejustin46: DISTINCT evolutionary pathways of OMICRON subvariants "Evolving antibody evasion and receptor affinity of the Omicron BA.2.…
New preprint: Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2 https://t.co/Itj3OEj14a #COVID19
RT @ejustin46: DISTINCT evolutionary pathways of OMICRON subvariants "Evolving antibody evasion and receptor affinity of the Omicron BA.2.…
DISTINCT evolutionary pathways of OMICRON subvariants "Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2" https://t.co/gKXSLYihck https://t.co/yNMdyO4KAe
bioArXiv_ Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2 https://t.co/VlUqqppyiA
Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2 https://t.co/RJ1bd3KNEO #biorxiv_micrbio
Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2 https://t.co/eIDiE7vPie #bioRxiv